15.03.2012 12:05 Uhr, Quelle: Wallstreet online

Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment

DUBLIN, March 15, 2012 /PRNewswire/  Shire plc , the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in …

Weiterlesen bei Wallstreet online